A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin

► Proof-of-principle new screen for BRCA2 VUS characterization. ► BRCA2 linker region influences cisplatin-induced cell death. ► VUS modify effect of BRCA2 linker region on cell response to cisplatin treatment.